CytoSPAR
Easton · Founded 2011
About CytoSPAR
CytoSPAR is a biomolecular engineering and diagnostic testing company. The company's platform is a cell-based targeting technique that is highly sensitive and produces results in less than 10 minutes. It is easily trained to recognize a broad spectrum of microbes, viruses, proteins, and antibodies.
Company Facts
- Founded: 2011
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.0M
- Last round: Series Unknown (May 2022)
- Website: https://cytospar.com/
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/cytospar-140968 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.